82Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
India
Neuroscience Intelligence
India neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #22 of 50 · Data maturity A · Research score 38.5 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
18Recruiting trials
281Publications
226Institutions
Executive interpretation
India ranks #22 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.90 recruiting
All India Institute of Medical Sciences41 recruiting
Newron Pharmaceuticals SPA40 recruiting
GlaxoSmithKline30 recruiting
Eli Lilly and Company31 recruiting
Boehringer Ingelheim20 recruiting
Neurovalens Ltd.20 recruiting
Hoffmann-La Roche21 recruiting
All India Institute of Medical Sciences, Bhubaneswar20 recruiting
Bristol-Myers Squibb22 recruiting
Disease activity
Epilepsy17trials
Parkinsons11trials
Other Neurology6trials
Depression5trials
Autism5trials
Schizophrenia5trials
Alzheimers5trials
Pain Neuropathy5trials
Stroke4trials
Migraine Headache3trials
Research institutions
Kerala Forest Research InstituteOpenAlexlinked institution
KIIT UniversityOpenAlexlinked institution
Indian Institute of Management AhmedabadOpenAlexlinked institution
Bose InstituteOpenAlexlinked institution
Indian Institute of Technology HyderabadOpenAlexlinked institution
Christian Medical CollegeOpenAlexlinked institution
Narayan Medical College and HospitalOpenAlexlinked institution
Odisha University of Agriculture and TechnologyOpenAlexlinked institution
Jadavpur UniversityOpenAlexlinked institution
Gujarat Technological UniversityOpenAlexlinked institution
Clinical evidence trail
NCT07797725Efficacy of Low Glycemic Index Diet vs Modified Atkins Diet and Gluten Free Casein Free Diet as add-on Therapy With Standard of Care in Children With Autism Spectrum DisorderNOT_YET_RECRUITING
NCT07743814EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) OF PRIMARY MOTOR CORTEX ON HEADACHE FREQUENCY IN PATIENTS WITH CHRONIC MIGRAINENOT_YET_RECRUITING
NCT07582380National Institute for Health and Care Research Global Health Research Centre for Multiple Long-Term ConditionsNOT_YET_RECRUITING
NCT07424404A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and AdolescentsRECRUITING
NCT07251218Assessing the Effects of Cool Roofs on Mental Health in Ahmedabad, IndiaACTIVE_NOT_RECRUITING
NCT07221669A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)RECRUITING
NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)RECRUITING
NCT06976216A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseRECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06744920A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia GravisRECRUITING
NCT06463587Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)RECRUITING
Research evidence trail
PUBMEDAuNP decorated-Ni-MOF nanosheet based cDNA sensor for detection of miRNA-128 in Alzheimer's disease.2027-02-01
PUBMEDA transdiagnostic evaluation of adult temperamental profiles and their interactions with childhood adversities across major psychiatric disorder.2026-12-15
PUBMEDExploring Barriers and Facilitators to Deprescribing Psychotropics in Child and Adolescent Psychiatry: A Qualitative Study from India.2026-12-01
PUBMEDCirculating miRNA signatures for the prediction of delayed cerebral ischemia (DCI) and cerebral vasospasm: scoping review.2026-12-01
PUBMEDExploring toothpaste ingredients as potential chemical kindling agents in neuropsychiatric disorders: An adult zebrafish (Danio rerio) study.2026-12-01
PUBMEDMRI-based oxygen extraction fraction mapping using qBOLD, QSM, and hybrid QSM-qBOLD methods: Methodological advances, validation, and clinical applications.2026-12-01
PUBMEDGaze fixation stability is a transdiagnostic marker of major psychiatric disorders: A high-density family-based study.2026-12-01
PUBMEDTinyDINO VHaar based Bi-directional Chameleon optimized LightASDNet for autism spectrum disorder detection.2026-12-01
PUBMEDSIRT1 activator resveratrol improves the ALF-induced cognitive and motor function deficits in rats via modulating glutamate-NMDAR-NOS-cGMP pathway.2026-11-17
PUBMEDK16ApoE-mediated delivery across the blood-brain barrier: mechanisms, applications, and translational challenges.2026-11-03
PUBMEDTargeting glioblastoma epigenetics: mechanisms, microenvironmental interplay, and therapeutic potential.2026-11-03
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.